A critical role of Sp1 transcription factor in regulating the human Ki-67 gene expression

Tumor Biology

Volumn 32, Issue 2, 2011, Pages 273-283

  Tian, Hui ^a   Qian, Guo Wei ^a   Li, Wang ^a   Chen, Fei Fei ^a   Di, Jie Hui ^a   Zhang, Bao Fu ^a   Pei, Dong Sheng ^a   Ma, Ping ^a   Zheng, Jun Nian ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Core promoter; EMSA; Ki 67; Proliferation marker; Sp1; Supershift

Indexed keywords

FIREFLY LUCIFERASE; KI 67 ANTIGEN; MESSENGER RNA; MITHRAMYCIN; PROTEIN ANTIBODY; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SP1; NUCLEIC ACID SYNTHESIS INHIBITOR;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION; ADENOCARCINOMA; DRUG EFFECT; GENETICS; HELA CELL; LUNG TUMOR; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; BASE SEQUENCE; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; KI-67 ANTIGEN; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID SYNTHESIS INHIBITORS; PLICAMYCIN; RNA, SMALL INTERFERING; SP1 TRANSCRIPTION FACTOR; UTERINE CERVICAL NEOPLASMS;

EID: 79953786027     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-010-0119-4     Document Type: Article

References (25)

1. Duchrow M, Schlueter C, Wohlenberg C, Flad HD, Gerdes J. Molecular characterization of the gene locus of the human cell proliferation-associated nuclear protein defined by monoclonal antibody Ki-67. Cell Prolif. 1996;29:1-12. (Pubitemid 26086057)
2. MacCallum DE, Hall PA. Biochemical characterization of pKi67 with the identification of a mitotic-specific form associated with hyperphosphorylation and altered DNA binding. Exp Cell Res. 1999;252:186-98. (Pubitemid 29485138)
3. Schlüter C, Duchrow M, Wohlenberg C, Becker MH, Key G, Flad HD, et al. The cell proliferation associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol. 1993;123:513-22. (Pubitemid 23324910)
4. MaCallum DE, Hall PA. Biochemical characterization of pKi-67 with the identification of a mitotic-specific form association with hyperphosphorylation and altered DNA binding. Exp Cell Res. 1991;52:186-98.
5. Kausch I, Jiang H, Ewerdwalbesloh N, Doehn C, Kruger S, Sczakiel G, et al. Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibition. BJU Int. 2005;95:416-20. (Pubitemid 40283136)
6. Dynan WS, Tjian R. Isolation of transcription factors that discriminate between different promoters recongnized by RNA polymerase II. Cell. 1983;32:669-80. (Pubitemid 13087925)
7. Dynan WS, Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell. 1983;35:79-87. (Pubitemid 14240221)
8. Suske G. The Sp-family of transcription factors. Gene. 1999;238:291-300. (Pubitemid 29446168)
9. Kadonaga JT, Carner KR, Masiarz FR, Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell. 1987;51:1079-90.
10. Endl E, Gerdes J. Post-translational modifications of the Ki-67 protein coincide with two major check points during mitosis. J Cell Physiol. 2000;182:371-80. (Pubitemid 30054371)
11. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311-22. (Pubitemid 30054364)
12. Takagi M, Matsuoka Y, Kurihara T, Yoneda Y. Chmadrin: a novel Ki-67 antigen-related perichromosomal protein possibly implicated in higher order chromatin structure. J Cell Sci. 1999;112:2463-72. (Pubitemid 29401669)
13. Yang X, Su K, Roos MD, Chang Q, Paterson AJ, Kudlow JE. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc Natl Acad Sci. 2001;98:6611-6. (Pubitemid 32538264)
14. Su K, Roos MD, Yang X, Han I, Paterson AJ, Kudlow JE. An N-terminal region of Sp1 targets its proteasome dependent degradation in vitro. J Biol Chem. 1999;274:15194-202.
15. Safe S, Abdelrahim M. Sp transcription factor family and its role in cancer. Eur J Cancer. 2005;41:2438-48. (Pubitemid 41540621)
16. Safe S, Kim K. Nuclear receptor-mediated transactivation through interaction with Sp proteins. Prog Nucleic Acid Res Mol Biol. 2004;77:1-36.
17. Bouwman P, Philipsen S. Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol. 2002;195:27-38. (Pubitemid 35287159)
18. Li L, He S, Sun JM, Davie JR. Gene regulation by Sp1 and Sp3. Biochem Cell Biol. 2004;82:460-71. (Pubitemid 39286961)
19. Barth N, Langmann T, Scholmerich J, Schmitz G, Schaffler A. Identification of regulatory elements in the human adipose most abundant gene transcript-1 (apM-1) promoter: role of SP1/SP3 and TNF-alpha as regulatory pathways. Diabetologia. 2002;45:1425-33. (Pubitemid 35244896)
20. Wang LW, Wei DY, Huang SY, Peng ZH, Le XD, Wu TT, et al. Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res. 2003;9:6371-80.
21. Shi Q, Le XD, Abbruzzese JL, Peng ZH, Qian CN, Tang HM, et al. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res. 2001;61:4143-54. (Pubitemid 32720983)
22. Chiefari E, Brunetti A, Arturi F, Bidart JM, Russo D, Schlumberger M, et al. Increased expression of AP2 and Sp1 transcription factors in human thyroid tumours: a role in NIS expression regulation. BMC Cancer. 2002;2:35.
23. Hosoi Y, Watanabe T, Nakagawa K, Matsumoto Y, Enomoto A, Morita A, et al. Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol. 2004;25:461-8.
24. Jang SI, Steinert PM. Loricrin expression in cultured human keratinocytes is controlled by a complex interplay between transcription factors of the Sp1, CREB, AP1, and AP2 families. J Biol Chem. 2002;277:42268-79. (Pubitemid 35257547)
25. Suzuki T, Kimura A, Nagai R, Horikoshi M. Regulation of interaction of the acetyltransferase region of p300 and the DNA-binding domain of Sp1 on and through DNA binding. Genes Cells. 2000;5:29-41. (Pubitemid 30095679)